Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
SUDEEPPHRM.NS
HoldPremium GrowerSudeep Pharma Limited · Healthcare · India · $1.6B · Avg Vol: $5M/d
41
StockRankGet insider-trade alerts
Q
70
V
12
M
52
P/E (TTM)
79.1x
ROE
19.6%
D/E
0.2x
Dividend %
0.1%
COMPANY DESCRIPTION
Sudeep Pharma Limited manufactures and sells excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries in India, the United States, and internationally.
FINANCIAL SUMMARY (INR)
| Year | 2023 | 2024 | 2025 | 2026 | CAGR | TTM | 2027E | 2028E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.3B | 4.5B | 5.0B | 6.4B | 14.4% | 6.8B | 7.2B | 9.3B | 20.9% |
| EPS (INR) | 5.52 | 11.79 | 12.28 | 15.50 | 41.1% | 16.20 | 17.30 | 19.35 | 11.7% |
| Shares | 112.9M | 112.9M | 112.9M | 112.9M | 0.0% | 112.9M | — | — | — |
| Debt | 830.8M | 780.8M | 1.4B | 1.5B | 21.9% | 1.5B | — | — | — |
| Equity | 2.2B | 3.6B | 4.9B | 8.8B | 58.2% | — | — | — | — |
| Op CF | 483.9M | 656.9M | 487.3M | 695.5M | 12.9% | 697.9M | — | — | — |
| Inv CF | -500.2M | -492.8M | -787.6M | -3.3B | — | — | — | — | — |
| Fin CF | -97.8M | -127.3M | 527.0M | 2.5B | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)+49.2%
SMA 50SMA 200
Close
$13.38
RSI (14)
76.2
SCORE BREAKDOWN
Quality
70
ROIC
24.0%93.7
ROE
19.6%88.0
GP/Assets
36.6%73.4
Op. Margin
32.2%93.2
FCF/Assets
-4.1%36.7
Piotroski
549.3
Int. Cover
42.9x77.4
D/E Ratio
0.17x53.5
Current Ratio
3.09x56.5
Value
12
P/E (TTM)
79.1x12.4
EV/EBITDA
65.8x8.3
P/FCF
—N/A
P/B
16.3x6.8
P/S
21.4x15.4
Div Yield
0.1%2.7
Momentum
52
52W High %
—N/A
RS 6M
111%97.2
SMA 50/200
—N/A
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+20%34.2
Q Growth
32%64.8
FUNDAMENTALS
Market Cap
$1.6B
P/E (Forward)
66.0x
Gross Margin
63.7%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of SUDEEPPHRM.NS are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| SUDEEPPHRM.NS | Sudeep Pharma Limited(you) | $1.6B | 41 | Hold |
| COHANCE.NS | Cohance Lifesciences Limited | $1.8B | 37 | Hold |
| ASTRAZEN.NS | AstraZeneca Pharma India Limited | $1.8B | 30 | Sell |
| SUVEN.NS | Suven Life Sciences Limited | $1.1B | 34 | Sell |
| ERIS.NS | Eris Lifesciences Limited | $1.9B | 55 | Hold |
| JUBLPHARMA.NS | Jubilant Pharmova Limited | $1.7B | 60 | Hold |
| ORCHPHARMA.NS | Orchid Pharma Limited | $517M | 45 | Hold |
| GUJTHEM.NS | Gujarat Themis Biosyn Limited | $622M | 52 | Hold |
| WOCKPHARMA.NS | Wockhardt Limited | $3.8B | 54 | Hold |
| PPLPHARMA.NS | Piramal Pharma Limited | $3.2B | 58 | Hold |
Peer medians: ROE 11.8% · P/E 42.5x · Gross margin 59.4%